Immuneering Announces Participation in Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, today announced that management will present the company’s pipeline, platform, and business strategy at the Jefferies Healthcare Conference and the H.C. Wainwright Global Investment Conference, details of which are set forth below.
Conference: Jefferies Healthcare Conference
Conference: H.C. Wainwright Global Investment Conference
The Jefferies presentation will be webcast live and archived for 30 days at https://wsw.com/webcast/jeff240/imrx/1869600, and the H.C. Wainwright presentation will be available on demand and archived for 30 days at https://journey.ct.events/view/3c2af387-6a8b-442b-82f7-4db414821c21.
About Immuneering Corporation